METTL3, methyltransferase 14, N6-adenosine-methyltransferase complex catalytic subunit (METTL14) and YTH N6-methyladenosine RNA binding protein 1/2 (YTHDF1/2) are m6A modifiers in human NSCLC and play oncogenic roles in this cancer [35]. This evidence concerns the gene METTL3 and cancer.